According to Cerus's latest financial reports the company's current earnings (TTM) are -$28.94 M. an increase over its 2022 earnings that were of -$36.51 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$28.94 M | -20.74% |
2022 | -$36.51 M | -25.7% |
2021 | -$49.14 M | -11.99% |
2020 | -$55.83 M | -14% |
2019 | -$64.92 M | 21.73% |
2018 | -$53.33 M | -0.65% |
2017 | -$53.68 M | -10.96% |
2016 | -$60.29 M | 4.24% |
2015 | -$57.84 M | 50.99% |
2014 | -$38.31 M | -10.08% |
2013 | -$42.6 M | 184.13% |
2012 | -$15 M | -7.91% |
2011 | -$16.28 M | |
2009 | -$23 M | -24.69% |
2008 | -$30.53 M | -25.2% |
2007 | -$40.82 M | 330.54% |
2006 | -$9.48 M | 1.49% |
2005 | -$9.35 M | -61.02% |
2004 | -$23.97 M | |
2002 | -$59.28 M | 10.02% |
2001 | -$53.88 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $1.98 B | -6,959.97% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $20.08 M | -169.43% | ๐บ๐ธ USA |
Haemonetics HAE | $0.17 B | -688.18% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | -$20.53 M | -29.08% | ๐บ๐ธ USA |